Continuous Flow Zuclomiphene Synthesis for Isomer Purity

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for preparing zuclomiphene result in isomeric mixtures enriched in the undesired E-isomer, leading to low yields and inefficiencies in separating the desired Z-isomer, making them unsuitable for commercial scale-up.

Innovation Solution

A continuous flow process involving nickel-catalyzed carbometallation of diphenylacetylene with a compound of Formula (3), followed by chlorination, which suppresses the formation of brominated impurities and enhances the selectivity for the Z-isomer, allowing for higher yields and reduced purification cycles.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Manufacturing precision

If conventional batch methods (Grignard addition, Horner-Emmons, or cross-coupling) are used for preparing clomiphene, then the synthesis can be completed, but the product is an isomeric mixture enriched in the undesired E-isomer with low Z-isomer content

Engineering Contradiction:
Improveisomeric purityVSAvoidyield of Z-isomer
Core Design Contradiction:
Manufacturing precisionVSProductivity

Solution Approach 1:

The patent changes the reaction parameters by using continuous flow chemistry instead of conventional batch methods. This involves controlling residence time, temperature, and reagent addition rates in a flow reactor to achieve high Z-isomer selectivity. The continuous flow process allows precise control of reaction conditions that favor Z-isomer formation while minimizing E-isomer formation, thereby improving both manufacturing precision and productivity.

Inventive Principle:
Principle #35Parameter changes

2Productivity

If conventional chlorination methods are used after carbometallation, then the reaction proceeds to completion, but significant brominated impurities (greater than 10%) are formed

Engineering Contradiction:
Improvereaction completionVSAvoidbrominated impurity formation
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent employs continuous flow chlorination where the carbometallated intermediate is continuously chlorinated in a flow reactor. This continuous process allows immediate conversion of the intermediate to the final product, preventing side reactions that lead to brominated impurities. The continuous action ensures complete reaction while minimizing impurity formation through controlled reagent exposure and rapid product formation.

Inventive Principle:
Principle #20Continuity of useful action

3Manufacturing precision

If fractional crystallization is used to separate Z-isomer from the isomeric mixture, then some purification is achieved, but the process requires multiple cycles and generates significant solvent waste

Engineering Contradiction:
Improveisomeric purityVSAvoidsolvent waste
Core Design Contradiction:
Manufacturing precisionVSLoss of substance

Solution Approach 1:

The patent performs preliminary action by designing the synthesis route to directly produce high-purity Z-isomer through continuous flow chemistry, avoiding the need for extensive downstream purification. The reaction conditions are optimized in advance to favor Z-isomer formation, and the continuous flow process inherently provides better mixing and heat transfer that enhance selectivity. This preliminary optimization of reaction conditions eliminates or minimizes the need for multiple fractional crystallization cycles, thereby reducing solvent waste.

Inventive Principle:
Principle #10Preliminary action

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The continuous flow process achieves higher isomeric purity of zuclomiphene, with less than 10% brominated impurity, improving yield and reducing solvent waste, making it more suitable for industrial application.

Implementation Method 1

nickel-catalyzed carbometallation of diphenylacetylene with a compound of Formula (3)

Methodology Applied
Scientific EffectCatalysis: Catalysis

Data Source

PatentUS11578025B2Processes for the preparation of zuclomiphene intermediates
Publication Date: 2023.02.14 APOTEX INC
  • US11578025B2 patent drawing
  • US11578025B2 patent drawing
  • US11578025B2 patent drawing

AI summary

The present invention provides continuous flow processes for the preparation of the compound of Formula (2-A), an intermediate used in the preparation of zuclomiphene or a salt thereof.